Navigation Links
Jury Rules in Favor of Glycoproducts International, Inc.
Date:5/28/2008

RIGGINS, Idaho, May 28 /PRNewswire/ -- Glycoproducts International, Inc., a provider of nutritional supplement products, today announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated's (Nasdaq: MTEX) patents relating to Mannatech's AMBROTOSE(R) technology.

The jury ruled in favor of Glycoproducts International, Inc., finding that they were innocent of patent infringement of Mannatech's U.S. Patent No. 6,929,807, the parent patent upon which the lawsuit against Glycoproducts International, Inc. was originally based. However, in regard to Mannatech's continuation patent of the parent patent, U.S. Patent No. 7,157,431, which was issued and first claimed to be infringed by Mannatech after the lawsuit was filed, the jury found that Glycoproducts International, Inc. had committed patent infringement.

The jury ruled in favor of Mannatech on its claims of infringement of the AMBROTOSE(R) trademark. Since Glycoproducts International, Inc. successfully defended its position against Mannatech's '807' parent patent, it will oppose Mannatech's request for an injunction to prohibit Glycoproducts International, Inc. from further production, distribution and sale of its Glycomannan(R) product.

Phil Moulton, president of Glycoproducts International, Inc. said, "Our product is distinctly different from Mannatech's products, and is a source of at least 10 of the 11 scientifically recognized biologically vital sugars, with minerals, bioflavonoids and other nutrients that naturally occur within the whole-food matrix."

"Our products are derived from natural sources and are not diluted with rice fillers," he stated.

The verdict was delivered on Friday, May 9, 2008, in the United States District Court for the Northern District of Texas, Dallas Division, following testimony before Fe
'/>"/>

SOURCE Glycoproducts International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
2. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
3. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
4. DARA Announces Information in Compliance with NASDAQ Rules
5. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
6. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
7. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
8. When the rules of the game are broken: Research studies sports injuries related to illegal activity
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Aetna Requires CAQH Core Rules Certification for Vendors
11. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...nversations with alleged lesbian pal deejay Samant... Girls' star kept in touch with her friends and re... magazine the access to the starlet's passionate c...n. In the conversations that appear under the tit...
...otect against the clustering of abnormal body chem... study in the Journal of Epidemiology and Communit...eased risk of diabetes, coronary artery disease, a...based on a representative sample of 2375 men aged ...
... Physicians (UK), the state of emergency services... audit entitled Myocardial Infarction National Aud...all in the percentage of people killed by heart at...wn 12.4 percent from last years figures, meaning 1...
...tion programs in low and middle-income countries, ...am unit costs to reduce . A UCSF-led team of rese... Other low and middle-income countries like Uganda... Russia were also assessed. "With the recent rep...
Other Medicine News:Health News:Survey Shows Emergency Services Of British Hospitals Doing A Good Job 2
(Date:8/14/2008)...Newswire-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: ...mmitted to,discovering, developing and commerciali...ed unaudited financial results for the third fisca... a net loss attributable to,common stockholders of...he,quarter ended June 30, 2008, as compared to a n...
(Date:8/14/2008)...14 /- The Clinical Trials,Bootcamp an...hysicians,clinical coordinators, clinical researc...It will be held in Boca Raton at the Boca Resort f...inical coordinators, monitors and,other industry p...orporate,clinical trials into a practice, as well ...
(Date:8/14/2008)...begin in late 2008 or in early 2009 -, SAN CARLOS..., Inc.,(Nasdaq: NUVO ) today announced positive r... NU172, demonstrating that the direct thrombin,inh...tion with a rapid,return toward baseline after the... "NU172 has the potential to address many of the l...
(Date:8/13/2008)...-FirstCall/ -- As biotechnology,pharmaceutical an...cal,trials beyond their own borders to other parts...uth America, complicated regulatory environments,c...rding to an analysis by,Aon Corporation (NYSE: AO...those companies a visual representation of the com...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 1Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 2Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 3Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 4Dead clams tell many tales 1007 1Dead clams tell many tales 1007 2Dead clams tell many tales 1007 3Dead clams tell many tales 1007 4Tiny radioactive spheres effectively treat cancer that has spread to the liver 4844 1Tiny radioactive spheres effectively treat cancer that has spread to the liver 4844 2New treatment option studied for bladder cancer 4839 1New treatment option studied for bladder cancer 4839 2New treatment option studied for bladder cancer 4839 3
...curs at the 55th Annual,Clinical Meeting of the Am... COLLEGEVILLE, Pa., May 09, 2007 /PRNewswire-First...h , presented results from the,first Phase 3 studi... treatment of moderate-to-severe vasomotor symptom...enopause. These studies showed,that women who took...
...- Results of a Phase 2a,clinical trial evaluating ...eat hospital acquired gram-negative bacterial,pneu...ociety (ATS),International Conference, May 18 - 23...S. Niederman, MD, Chairman, Department of, ...or of, Medicine; Vice Chairman, Departme...
Other Medicine Technology:Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: